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activation of human and Mouse 
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Benoit T. Roux1, James A. Heward2, Louise E. Donnelly3, Simon W. Jones4  
and Mark A. Lindsay1,3*
1 Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom, 2 Barts Cancer Institute, Queen 
Mary University of London, London, United Kingdom, 3 Airway Disease, National Heart and Lung Institute, Imperial College, 
London, United Kingdom, 4 Institute of Inflammation and Ageing, MRC-ARUK Centre for Musculoskeletal Ageing Research, 
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Despite increasing evidence to indicate that long non-coding RNAs (lncRNAs) are novel 
regulators of immunity, there has been no systematic attempt to identify and characterize 
the lncRNAs whose expression is changed following the induction of the innate immune 
response. To address this issue, we have employed next-generation sequencing data to 
determine the changes in the lncRNA profile in four human (monocytes, macrophages, 
epithelium, and chondrocytes) and four mouse cell types (RAW 264.7 macrophages, 
bone marrow-derived macrophages, peritoneal macrophages, and splenic dendritic 
cells) following exposure to the pro-inflammatory mediators, lipopolysaccharides 
(LPS), or interleukin-1β. We show differential expression of 204 human and 210 mouse 
lncRNAs, with positional analysis demonstrating correlation with immune-related genes. 
These lncRNAs are predominantly cell-type specific, composed of large regions of repeat 
sequences, and show poor evolutionary conservation. Comparison within the human and 
mouse sequences showed less than 1% sequence conservation, although we identified 
multiple conserved motifs. Of the 204 human lncRNAs, 21 overlapped with syntenic 
mouse lncRNAs, of which five were differentially expressed in both species. Among 
these syntenic lncRNA was IL7-AS (antisense), which was induced in multiple cell types 
and shown to regulate the production of the pro-inflammatory mediator interleukin-6 in 
both human and mouse cells. In summary, we have identified and characterized those 
lncRNAs that are differentially expressed following activation of the human and mouse 
innate immune responses and believe that these catalogs will provide the foundation for 
the future analysis of the role of lncRNAs in immune and inflammatory responses.
Keywords: long non-coding rna, innate immunity, conserved motif, human catalog, mouse catalog, inflammation
Abbreviations: BMDM, bone marrow-derived macrophages; mRNA, messenger RNA; ncRNA, non-coding RNA; lncRNA, 
long non-coding RNA; lincRNA, long intergenic non-coding RNA; IL, interleukin; LPS, lipopolysaccharide; nt, nucleotide.
2Roux et al. LncRNA, Innate Immunity and Inflammation
Frontiers in Immunology | www.frontiersin.org August 2017 | Volume 8 | Article 1038
inTrODUcTiOn
High-throughput sequencing indicates that much of the human 
genome is transcribed into non-coding RNAs (ncRNAs) with 
estimates of the proportion varying from ~62% predicted by the 
ENCODE project (1) to ~10% based on evolutionary conserva-
tion (2). By absolute amount, the majority of ncRNAs (>90%) are 
involved in house-keeping activities such as translation, splic-
ing, and post-transcriptional RNA modifications and include 
ribosomal RNAs, transfer RNAs, short nucleolar RNAs, and 
small nuclear RNAs (3, 4). The remaining ncRNAs are broadly 
classified as either short ncRNAs [<200 nucleotides (nt)] or long 
ncRNAs (lncRNAs) (>200 nt) (4). The microRNA family of short 
ncRNAs is the best characterized and is known to induce mes-
senger RNA (mRNA) degradation or block mRNA translation 
via the RNA interference pathway (5). By contrast, much less in 
known about lncRNAs, although, by comparison with mRNAs, 
their expression is cell specific and they are generally shorter in 
length, contain fewer exons, and are expressed at lower levels 
(6, 7). Presently, lncRNAs are classified by their relative posi-
tion to protein-coding mRNAs and include the long intergenic 
ncRNAs (lincRNAs), antisense (AS), and pseudogenes (8). 
Although there is accumulating evidence showing that lncR-
NAs are regulators of a host of physiological and pathological 
responses, our understanding of their mechanism of action 
is limited. By analogy with protein-coding genes, it has been 
speculated that this is mediated through domains that interact 
with proteins and/or base pair with RNA/DNA (9). However, the 
identification of these domains has been hindered by their poor 
evolutionary conservation, which, in contrast to protein-coding 
genes, does not require the maintenance of a conserved open 
reading frame for optimal translation (6). Instead, it is thought 
that the lncRNAs conservation is geared toward the maintenance 
of genomic position (synteny), short domains (microdomains), 
and secondary structure (7, 10).
The innate immune response provides the initial defense 
against infection by external pathogens through induction of an 
inflammatory response. The presence of pathogens is commonly 
detected by cells of the myeloid family, including tissue resident 
macrophages, dendritic cells, and circulating blood monocytes 
(11, 12). These cells express families of pattern recognition 
receptors that bind conserved molecules within bacteria, fungi, 
and viruses including lipoproteins, lipopolysaccharides (LPS), 
bacterial CpG motifs, and single/double-stranded RNA. Many 
families of pattern recognition receptors have been identified, 
although the best characterized are the toll-like receptor and 
interleukin-1β (IL1β) receptor superfamily. Activation of Toll-like 
receptors stimulates the production of inflammatory mediators 
via transcription factors including nuclear factor-κB (NF-κB). 
This leads to a spectrum of responses including the release of 
multiple inflammatory mediators, as well as the activation of 
the inflammasome and the subsequent production of IL1β. The 
latter then induces a potent inflammatory response in the sur-
rounding stromal cells such as the epithelium, chondrocytes, and 
fibroblasts (11, 12).
Recent publications have identified a number of lncRNAs 
that are differentially expressed following activation of innate 
immunity and which regulate the subsequent inflammatory 
response. In human cells, these include PACER (p50-associated 
COX-2 extragenic RNA) (13), THRIL (TNFα- and hnRNPL-
related immunoregulatory lincRNA) (14), lnc-IL7R (15), and 
IL1β-RBT46 (16), while studies in mice have identified lincRNA-
COX2 (17, 18), lincRNA-EPS (19), and lincRNA-Tnfaip3 (20). 
However, despite these early indications that lncRNAs act as 
novel regulators, there has been no systematic attempt to identify 
lncRNAs whose expression is changed following the induction of 
the innate immune response. To address this issue, we determined 
the changes in lncRNA profile in four human and four mouse 
cell types following exposure to LPS or IL1β. From this analysis, 
we have cataloged and characterized 204 human and 210 mouse 
lncRNAs that are differentially expressed following activation of 
the innate immune response. We have then employed this list of 
potentially immune modulatory lncRNAs, to identify conserved 
microdomains and syntenic lncRNAs. To confirm the biologi-
cal relevance of this analysis, we have shown that the lncRNA 
IL7-AS [located AS to interleukin-7 (IL7) gene] is induced across 
multiple human and mouse cell types and regulates the expres-
sion and hence the release of the pro-inflammatory mediator, 
interleukin-6 (IL6).
MaTerials anD MeThODs
isolation and Treatment of human 
Monocytes and Macrophages
Human monocytes were prepared as previously described (16). 
To obtain monocyte-derived macrophages, monocytes were re-
suspended in MDM complete media [RPMI-1640 supplemented 
with 10% (v:v) Fetal Calf Serum, 2 mM l-glutamine, 100 U/ml 
penicillin, and 100  µg/ml streptomycin; all GIBCO, Life 
Technologies] and seeded onto six-well black plates (106 cells/
well) for 2 h at 37°C, 5% (v:v) CO2 to allow monocytes to adhere 
to the plate. Non-adherent cells were aspirated, and monocytes 
were incubated with fresh complete media containing GM-CSF 
(2 ng/ml; R&D Systems). Monocytes were incubated at 37°C, 5% 
(v:v) CO2 for 12 days to allow full differentiation into MDMs; 
fresh media containing GM-CSF were replenished on days 4 
and 7. Cells were treated with 10  ng/ml LPS for 4  h, and the 
controls were left untreated. The media was then removed, and 
the cells lysed prior to RNA extraction. Circulating blood was 
collected upon obtaining informed consent, and the study was 
approved by the National Research Ethics Service (NRES 13/
LO/0354).
Production and Treatment of human 
chondrocytes
For the isolation of primary human chondrocytes, articular carti-
lage was digested using filter-sterilized collagenase IIA (2 mg/ml; 
Sigma Aldrich) for 5 h at 37°C. Digested cartilage was then filtered 
by passing through a 40-µm cell strainer (BD Biosciences), and 
the filtrate centrifuged. Chondrocytes were then resuspended in 
growth media [DMEM supplemented with 10% (v:v) FCS, 2 mM 
l-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, non-
essential amino acids 5% (v:v); all GIBCO, Life Technologies, 
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and 2  µg/ml amphotericin; Sigma Aldrich]. Cells were grown 
to 70–80% confluence and, then, either stimulated with 1 ng/ml 
IL1β for 4  h, and the controls were left untreated. OA patient 
joint tissue was collected from the Royal Orthopaedic Hospital 
(Birmingham) upon obtaining informed consent from patients 
undergoing elective joint replacement surgery. The study was 
approved by the NRES (14/ES/1044).
culture and Treatment of human epithelial 
a549 cells
Human epithelial A549 cells were cultured in growth media 
[DMEM/F-12 supplemented with 10% (v:v) FCS, 2  mM l- 
glutamine, 100 U/ml penicillin, and 100 µg/ml streptomycin; all 
GIBCO, Life Technologies] and incubated in a 37°C, 5% (v:v) 
CO2 humidified incubator. For all experiments, A549 cells were 
seeded in 24-well plate at 1–5 × 105 cell/well and stimulated with 
30 ng/ml IL1β (recombinant, Escherichia coli; Sigma Aldrich) for 
4 and 24 h, and the controls were left untreated.
culture and Treatment of human 
Monocytic ThP-1 cells
THP-1 cells were cultured in growth media [RPMI supplemented 
with 10% (v:v) FCS, 2  mM l-glutamine, 100  U/ml penicillin, 
100  µg/ml streptomycin, and 50  nM of 2-mercaptoethanol; all 
GIBCO, Life Technologies] and incubated in a 37°C, 5% (v:v) 
CO2 humidified incubator. For all experiments, THP-1 cells were 
seeded in 24-well plate at 5–8 × 105 cell/well and stimulated with 
1 µg/ml LPS (E. coli 055:B5; Sigma Aldrich) for 4 and 24 h, and 
the controls were left untreated.
culture and Treatment of Mouse raW 
264.7 Macrophages
RAW 264.7 cells were cultured in growth media [DMEM sup-
plemented with 10% (v:v) FCS, 2  mM l-glutamine, 100  U/ml 
penicillin, and 100  µg/ml streptomycin; all GIBCO, Life 
Technologies] and incubated in a 37°C, 5% (v:v) CO2 humidified 
incubator. For all experiments, RAW cells were seeded in 24-well 
plate at 2–5 ×  105  cell/well and stimulated with 1  µg/ml LPS 
(E. coli 055:B5; Sigma Aldrich) for 4 and 24 h, and the controls 
were left untreated.
rna isolation and Quality control
For all samples, total RNA was extracted using the RNeasy kit 
(Qiagen), included an on-column DNase treatment (Qiagen), 
according to the manufacturer’s guideline. RNA concentration 
was determined using the Qubit 2.0 (Life Technologies). RNA 
quality was measured using the Agilent Bioanalyser and produced 
RIN values >8.0.
rna library Preparation and sequencing
Total RNA from epithelial A549 and RAW 264.7 cells were 
purified using polyA  +  fractionation (Illumina), while the 
monocytes, macrophages, and synovial chondrocytes were 
subjected to ribosome depletion (Ribo-Zero, Illumina). For 
all tissues, cDNA libraries were prepared using the Illumina 
TruSeq Stranded Total RNA kit. Samples were then subjected 
to 100  bp, paired-end sequencing upon an Illumina 2000 
or 2500 sequencing machine (Wellcome Trust Sequencing 
Unit, University of Oxford). Quality scores across sequenced 
reads were assessed using FASTQC v0.9.2.1 All samples were 
of high quality with the average score (mean and median) 
at each base across reads in each sample Q >  35. Historical 
mouse sequencing data were download from Sequence Read 
Archive (SRA)2 using the following command in SRA tools: 
fastq-dump -I --split-files <file_name>. This included data 
on bone marrow-derived macrophages (BMDMs) (ribozero, 
paired-end, and non-stranded, n =  2) (19), peritoneal mac-
rophages, and splenic dendritic cells (ribozero, paired-end, 
and non-stranded, n = 2) (21).
alignment and assembly of human and 
Mouse lncrnas
Paired-end reads were aligned to the human reference genome 
(hg38) using TopHat2 (version 2.1.0) (22) or the mouse reference 
genome (mm10) using Hisat2 (version 2.0.4) (23) using the fol-
lowing command line options. Tophat2: tophat --library-type 
fr-firststrand <reference_genome.gtf> -1 <forward_strand.fa> 
-2 <reverse_strand.fa> -o <output.sam>. Hisat2: hisat2 -q 
--dta --rna-strandness FR –x <reference_genone.gtf> -1 
<forward_strand.fa> -2 <reverse-strand file.fa> –S <output.
sam>. Output SAM files were then sorted and converted to 
BAM files (samtools sort -@ 8 –o output.bam output.sam) and 
indexed (samtools index –b output.bam) in Samtools (24). The 
BAM output files for all control and LPS or IL1β samples were 
merged using Bamtools (25) to produce two files per cell type. 
All possible genes from these two BAM files were assembled ab 
initio using StringTie (26, 27) using the following command line 
options: stringtie <input.bam> -o assembled_genes.gtf -e –A 
gene_quantification.txt. The eight GTFs containing the genes 
from across the four cell types (both control and activated) 
were then combined using Cuffmerge v2.2.1.0 (which is part 
of the Cufflinks suite) (28) to produce a “total” GTF containing 
all possible genes and converted into a BED file. The single 
and multiple exon genes were separated using the information 
obtained in column 10 (block/exon), and those genes <200 
nucleotides were removed using the information in column 11 
(exon lengths). The resulting two BED files containing single 
exon and multi-exonic genes were compared with Gencode 
v23 (29) using BEDtools 2 (30) to identify known and novel 
lncRNAs. Potential protein-coding genes were identified using 
the coding potential calculator3 (31). The GTF containing novel 
single and multi-exonic lncRNAs was concatenated with the 
Gencode v23 catalog (29), to produce a “master” human GTF 
employed for gene quantification using CuffNorm, Stringtie, 
and CuffDiff. Parallel analysis of the expression of protein-
coding genes and lncRNAs in mouse was undertaken using 
Gencode m12 (32).
1 http://www.bioinformatics.babraham.ac.uk/projects/fastqc.
2 https://www.ncbi.nlm.nih.gov/sra.
3 http://cpc.cbi.pku.edu.cn.
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Principle component analysis  
and hierarchical clustering
The abundance of potential lncRNAs and Gencode v23 defined 
genes in individual samples was defined as the fragments per 
kilobase exon per million reads mapped (FPKM) and determined 
using CuffNorm v2.2.1.1 (part of the Cufflinks suite) (28). PCA 
and hierarchical clustering on Gencode v23 genes demonstrating 
an expression >1 FPKM were performed using Genesis (v1.7.7) 
(33). Data were log2 transformed following the addition of 1 
FPKM. The threshold for reporting gene expression at FPKM > 1 
is based upon the ability to validate sequencing data using qRT-
PCR (34).
Differential mrna and lncrna expression
The differential expression of assembled lncRNAs and Gencode-
annotated protein-coding genes was assessed with the geometric 
option (DESeq) in Cuffdiff v2.2.1.3 (part of the Cufflinks suite) 
(28) using a significance threshold of q < 0.05. The command line 
options were as follows: cuffdiff --FDR = 0.05 --min-alignment-
count =  10 --library-norm-method =  geometric --dispersion-
method  =  pooled -u <reference_genome.gtf> <control_1.
bam>, <control_x.bam>, <activated_1.bam> <activated_x.
bam> -o <output_file_name>.
assembly of lncrna gene sequences
A BED file containing all the transcripts for each lncRNAs was 
extra cted from the “master” GTF files and the exons extracted 
using the Gene BED to Exon/Intron/Codon BED expander (at 
www.usegalaxy.org) (35). Overlapping exons (genomic coordi-
nates) from each transcript were merged using Bedtools 2 (30), the 
relevant DNA sequences were extracted using Extract Genomic 
DNA (at www.usegalaxy.org) (35), and all exons sequences 
merged to produce a FASTA of the lncRNA gene sequences.
Determination of evolutionary 
conservation
A BED file containing all the transcripts for each lncRNAs was 
extracted from the master GTF files and submitted into the Table 
Browser Tool on the UCSC genome browser for comparative 
genomics4 (36).
identification and removal of repeat 
sequences
Repeat sequences were identified and removed from the assem-
bled lncRNA sequences (FASTA) using the default options in 
Repeatmasker.5
identification of conserved Microdomains
Potential motifs within the lncRNA genes were identified by 
submitting gene sequences (FASTA) into MEME-ChIP option 
on MEME-Suite (37). Identification of conserved sequences 
between lncRNAs was undertaken with BLAST+ (38) by input 
4 https://genome.ucsc.edu/cgi-bin/hgTables.
5 http://www.repeatmasker.org.
of the FASTA files as both query and subject using the follow-
ing command line: blastn -query <query_file.fasta> -subject 
<subject_file.fasta> -task blastn -outfmt “6 qacc sacc sseq 
pident qlen length evalue”> output.txt. These were compared 
with random control sequences of comparable lengths and 
AT ratios generated in the Build Controls Section (random 
sequences) of RSAT6 (39), while random protein-coding 
sequences of comparable lengths were selected from the mRNA 
sequences downloaded via Biomart in Ensembl.7 Output from 
all these BLASTn analyses (FASTA) was then submitted to 
MEME-ChIP.
identification of syntenic lncrnas
To identify syntenic lncRNA in the human and mouse catalogs, 
we used the Liftover program8 (36) to identify the predicted 
position of the human lncRNAs (hg38) on the mouse genome 
(mm10) and then examined whether these overlapped with the 
assembled mouse lncRNAs using Bedtools 2 (30).
chiPseq analysis
ChIPseq sequencing files (FASTQ) containing information on 
H3K27ac and H3K4me3 deposition and related input controls 
(n = 2 per condition), from control and LPS-stimulated human 
monocytes at 4  h (GSE85245) (40), were download from SRA 
(see text footnote 2) using SRA tools: fastq-dump <file_name>. 
Sequencing data were aligned to hg38 using Bowtie 2 (41): 
bowtie2 -q --very-fast <reference_genome.gtf> -U <file_name.
fastq> -S <output_file.sam>. Output SAM files were then sorted 
and converted to BAM files (samtools sort -@ 8 –o output.
bam output.sam), indexed (samtools index –b output.bam) 
in Samtools (24), and then converted to BigWig format using 
BamCoverage, which is part of the deepTools suite (42) using 
the following command line: bamCoverage -b <input_bam.
bam> --normalizeUsingRPKM --binSize 30 --smoothLength 
300 -p 10 --extendReads 200 –o <output_file.bw>. Significant 
ChIPseq peaks (n = 2 pre-condition and q = <0.1) were called 
with MACS2 (43) using the broadpeak options: macs2 callpeak –t 
<sample_1> <sample_2> -c <control_1> <control_2> -broad 
<output_files> -g hs. The intersection between ChIPseq data 
(broadpeak.bed) and mRNA and lncRNA was undertaken using 
the Join option in the Operate upon Genomic Intervals section 
of Galaxy (at www.usegalaxy.org) (35). Heatmaps of the data 
were generated using deepTools. Matrices containing summary 
scores around promoters were generated from the H3Kme3 and 
H3K27ac BigWig files using the following options in the com-
puteMatrix tool: computeMatrix reference-point -S <filename.
bw> -R <mRNA/lncRNA.bed> -b 3000 -a 3000 -out <matrix.
name>. Heatmaps were then generated using the plotHeatmap 
function and the following options: plotHeatmap -m <matrix.
name> --colorMap YlOrRd --samplesLabel “<Sample Names>” 
-out <plot_name.eps>.
6 http://rsat.sb-roscoff.fr.
7 http://www.ensembl.org/index.html.
8 http://genome.ucsc.edu/cgi-bin/hgLiftOver.
5Roux et al. LncRNA, Innate Immunity and Inflammation
Frontiers in Immunology | www.frontiersin.org August 2017 | Volume 8 | Article 1038
nuclear-cytoplasm rna Fractionation
A549 and THP-1 cells were stimulated with IL1β (30 ng/ml) 
or LPS (1 µg/ml) for 4 h respectively. The cells were scraped 
(i.e., A549) and/or collected, then centrifuged (12,000 ×  g, 
1  min, 4°C). Supernatants were discarded, and the pellets 
resuspended in 1 ml of cold PBS and then split into two equal 
fractions (500  µl each). Fractions were then centrifuged, 
and their supernatants discarded. One of the two fractions 
was resuspended and lysed in 350 µl of RLT buffer (Qiagen) 
and constituted the whole lysate fraction. The pellet of the 
remaining fraction was resuspended in 175  µl of cold RLN 
buffer [50 mM Tris pH 8, 140 mM NaCl, 1.5 mM MgCl2, 0.5% 
(v:v) Non-idet P-40, 0.5 mM DDT, 1× Halt protease inhibitor 
cocktail; Thermo Fisher, and 20 U/ml SUPERase-IN; Ambion] 
and incubated on ice for ~15 min, in order to lyse the plasma 
membrane while leaving the nuclei intact. The nuclei were 
then isolated by centrifugation (300 ×  g, 10  min, 4°C). The 
supernatant was delicately collected and transferred into a 
fresh tube, and 600 µl of RLT buffer was added to it to consti-
tute the cytoplasmic fraction while, the pellet was resuspended 
in 350  µl of RLT buffer to form the nuclear fraction. Total 
RNA was then extracted, and cDNA libraries were made 
using a set volume of RNA determined by the whole lysate 
fraction RNA quantity, within individual experiments. mRNA 
and RNA expressions were then determined using qPCR, and 
results were expressed as fold change compared to whole lysate 
stimulated samples.
Transfection of ThP-1, raW 264.7,  
and a549 cells with as locked nucleic  
acid gapmers
The following protocol was used to transfect all cell types (i.e., 
human monocytic THP-1 cells, mouse macrophage RAW 264.7 
cells, and human epithelial A549 cells). AS Locked Nucleic Acid 
(LNA) GapmeRs (Exiqon, sequences are listed in Table S1 in 
Supplementary Material, final concentration of 30  nM) were 
mixed in 100  µl of serum- and antibiotic-free medium, sup-
plemented with 5 µl of HiPerFect (Qiagen). Each mix was then 
added to each well of a 24-well plate. Cells were resuspended at 
desired concentration (1–8 ×  105  cells/well) in 100  µl of their 
corresponding complete medium and added on top of the LNA 
GapmeRs mixes. Cells were then incubated for 16 h. The follow-
ing day cells were diluted with 400 µl of complete medium and 
stimulated with either LPS or IL1β. Cells’ supernatants were then 
collected for the analysis of cytokine release (see ELISA), and 
cells were lysed for RNA extraction at 4 and 24 h. mRNA and 
RNA expressions were then determined using qPCR, and results 
were expressed as fold change compared to non-transfected 
stimulated samples.
cytokine release Measurement by elisa
Following stimulation of A549, THP-1, and RAW 264.7 cells, 
supernatants were collected and measurements of human and 
mouse IL6 were made by ELISA (R&D Systems) according to the 
manufacturer’s guidelines. Results are expressed in percentage of 
maximum response of control stimulation.
availability of Data and Materials
All software, including the web address of the source code, is 
listed in Table S2 in Supplementary Material. The sequencing 
data are available from the gene expression omnibus under the 
following entries: human monocytes (ERA294222), human 
macrophages (GSE101868), human chondrocytes (GSE74220), 
human lung epithelial A549 cells (GSE101868), mouse RAW 
264.7 macrophages (GSE101868), BMDMs (PRJEB11889), 
peritoneal macrophages, and splenic dendritic cells (SRP038980).
resUlTs
Differential expression of Protein-coding 
genes following activation of the human 
innate immune response
We undertook stranded and paired-end sequencing data on 
total RNA obtained from four activated human cell types associ-
ated with the innate immune response including two myeloid 
immune cells, monocytes (ERA294222) and monocyte-derived 
macrophages (macrophages) (GSE101868), and two stromal 
cell types, lung A549 epithelial cells (GSE101868) and synovial 
chondrocytes (GSE74220). The myeloid cells were activated with 
bacterial LPS (via TLR4), while the stromal cells were activated 
using the pro-inflammatory cytokine, IL1β. Sequencing pro-
duced 2.0 billion reads (100 bases per read) of which 87% could 
be aligned to the human reference genome. Principle component 
analysis and unsupervised hierarchical clustering of the mRNA 
expression data (>1 FPKM) demonstrated separation of control 
and activated monocytes, macrophages, chondrocytes, and 
epithelial cells (Data Sheet S1 in Supplementary Material). Using 
the Gencode database (v23), we showed differential expression 
(q < 0.05) of 1,955 mRNAs in monocytes, 1,386 mRNAs in mac-
rophages, 1,708 mRNAs in epithelial cells, and 855 mRNAs in 
chondrocytes (Table S3 in Supplementary Material). Integration 
of the data identified 3,853 mRNAs that were differentially 
expressed across all cell types. Of these, 2,479 (65%) were 
expressed in a single cell type, 858 (22%) were expressed in two 
cell types, 347 (9%) were expressed in three cell types, and 166 
(4%) were expressed in four cell types (Figure 1A). As might be 
expected, KEGG pathway analysis (using DAVID bioinformatics 
platform) (44) showed that the 2,359 differentially up-regulated 
mRNAs across all four cell types were associated with activation 
of the innate immune response (Figure 1B). In contrast, the 1,494 
down-regulated mRNAs were not associated with any pathways. 
These data indicated activation of the innate immune response 
in all four cell types following exposure to either of the pro-
inflammatory mediators, LPS or IL1β.
Profile of lncrna expression in resting 
human cells
We identified 1,162 lncRNA genes that contained at least two 
exons and were expressed at >1 FPKM in at least one cell type 
(either control or stimulated cells) (Figure  1C; Table S4 in 
Supplementary Material). For clarity, we have included the “h” 
and “m” prefixes to identify human and mouse lncRNAs. Of 
FigUre 1 | Profile of messenger RNAs’ (mRNAs) and long non-coding RNAs’ (lncRNAs) expressions in human cells. (a) Venn diagram showing the overlap in the 
differentially expressed mRNAs following lipopolysaccharides (LPS)-induced activation of monocytes and macrophages or IL1β-induced activation of epithelial cells 
and chondrocytes at 4 h. (B) Pathways analysis of the mRNAs that were differentially expressed across all human cell types. (c) Venn diagram showing the overlap 
in the lncRNAs expression profile in resting monocytes, macrophages, epithelial cells, and chondrocytes. (D) Distribution of different antisense and lincRNA species 
in resting monocytes, macrophages, epithelial cells, and chondrocytes and (e) Pie chart showing the percentage distribution of repeat sequences in the total 
lncRNA population obtained from all cell types.
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these assembled genes, 586 overlapped with lncRNAs annotated 
in Gencode v23, meaning that the remaining 576 (50%) likely 
represent novel lncRNAs. Detailed breakdown identified 469 
lncRNAs (54% novel) in monocytes, 248 lncRNAs (40% novel) 
in macrophages, 273 lncRNAs (32% novel) in epithelium, and 526 
lncRNAs (44% novel) in chondrocytes. As in previous reports, we 
divided lncRNAs into four groups based upon their relative posi-
tion to protein-coding genes: AS (overlapping a protein-coding 
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gene on the opposite strand), AS-upstream (within 5  kb and 
located upstream/opposite strand from of a protein-coding 
genes), AS-downstream (within 5 kb and located downstream/
opposite strand from of a protein-coding genes), and lincRNAs 
(located >5  kb from a protein-coding gene) (16). We have 
excluded lncRNAs located on the same strand and within 5 kb 
of a protein-coding gene, since these could potentially represent 
gene extensions. Using these criteria, it was found that lncRNAs 
could be subdivided into 39% AS, 5% AS-downstream, 8% 
AS-upstream, and 48% lincRNA, and this ratio remained similar 
across the four cell types (Figure 1D).
Examination of the overlap showed that the vast majority of 
lncRNA were expressed in a cell-specific manner with 906 (78%) 
selectively expressed in a single cell type, 182 (16%) in two cell 
types, 51 (4%) in three cell types, and 23 (2%) in all four cell types 
(Figure 1C; Table S4 in Supplementary Material). As previously 
reported (45), the lncRNAs were found to be enriched with repeat 
sequences (identified using repeatmasker.org) including 9.4% 
short interspersed nuclear elements (SINES), 9.7% long inter-
spersed nuclear elements (LINES), 7.6% long terminal repeats 
(LTRs), and 3.4% DNA elements, leaving 70% of non-repeat 
sequence (Figure 1E).
We have identified 1,162 lncRNAs across the four human cell 
types including 576 novel lncRNAs that were enriched in repeat 
sequences and expressed in a predominantly cell-specific manner.
Widespread Differential expression  
of lncrnas following activation of the 
human innate immune response
To identify lncRNAs that might regulate the innate immune 
response, we examined their differential expression following 
exposure to either LPS (monocytes and macrophages) or IL1β 
(epithelium and chondrocytes) (Table S5 in Supplementary 
Material). We showed differential expression of l05 lncRNAs 
in monocytes, 50 lncRNAs in macrophages, 39 lncRNAs in epi-
thelium, and 65 lncRNAs in chondrocytes (Figures 2A,B; Table 
S5 in Supplementary Material). This produced a total of 204 
differentially expressed lncRNAs, which could be subdivided 
into 127 lincRNAs (62%), 45 AS (22%), 17 AS-downstream 
(8%), and 15 AS-upstream (8%). Comparison with Gencode 
v23 showed that 93 lncRNAs overlapped with annotated genes, 
indicating that the remaining 111 might be novel (Table S5 in 
Supplementary Material). Evaluation of the absolute change in 
expression across the four cell types showed a 10-fold difference 
between differentially expressed mRNAs and lncRNAs, with a 
mean (±SEM) of 55.5 ± 3.1 FPKM and 5.4 ± 3.1 FPKM, respec-
tively. As with mRNAs, examination of the overlap between 
cell types showed that the vast majority (161 or 79%) were 
differentially expressed in a cell-specific manner (Figure 2B). 
Of the remainder, 33 (16%) were found in two cell types, eight 
(4%) in three cell types, and only two (1%) in all four cell types 
(Figure 2B).
Once again, large regions of repetitive sequences were found 
in AS (33%), AS-downstream (39%), AS-upstream (25%), and 
lincRNA (33%) (Figure 2C). To assess their potential function, 
we identified 699 genes located within 1 Mb of these differentially 
expressed lncRNAs using GREAT9 and showed that these were 
associated with immune activation and response (Figure  2D). 
Comparison of the fold change showed a correlation between 
expression of the nearest mRNA expression and that of the AS 
(r = 0.495, p < 0.0001), AS-downstream (r = 0.567, p < 0.0001), 
AS-upstream (r = 0.760, p < 0.0001), and lincRNAs (r = 0.520, 
p < 0.0001) (Figure 2E), which was not seen when we looked at 
the total lncRNA population (Data Sheet S2 in Supplementary 
Material).
In summary, we identified 204 lncRNAs that were differen-
tially expressed across the four human cell types (including 111 
novel lncRNAs) that could be subdivided into 62% lincRNAs, 
22% AS, and 8% AS-downstream and 8% AS-upstream. The 
majority (161 lncRNAs) were expressed in a cell-specific manner, 
although there were 43 lncRNAs that were induced in multiple 
cell types. Positional analysis showed that lncRNA expression was 
correlated with immune-related genes and suggested that these 
might be functionally linked.
Differential expression of single exon 
lncrnas during activation of the human 
innate immune response
Although we had included only multi-exonic genes in our initial 
analysis, a number of the previous publications have identified 
single exon lncRNAs that regulate the innate response, including 
PACER (13) and THRIL (14). To provide a complete picture of 
the role of non-coding RNAs in the innate immune response, 
we therefore decided to include these in the analysis. Our ab 
initio assembly identified 44,656 single exon lncRNAs genes that 
were >200 nt and expressed at >1 FPKM in at least one cell type 
(either control or stimulated cells) (Table S6 in Supplementary 
Material). Significantly, the vast majority (42,085 or 94%) showed 
no overlap with annotated lncRNAs in Gencode v23, while 
breakdown by cell type identified 8,068 lncRNAs in monocytes, 
313 lncRNAs in macrophages, 2,657 lncRNAs in epithelium, and 
37,829 lncRNAs in chondrocytes. The wide variation between 
cell types indicated that identification might be influenced by 
sequencing variability and that many of these single exons lncR-
NAs likely represent artifacts.
With these reservations in mind, we proceeded to identify 
those that were differentially expressed following activation of the 
innate immune response. Once again there was wide variation 
between cells with 510, 216, 33, and 710 differentially expressed 
lncRNAs in monocytes, macrophages, epithelium, and chon-
drocytes, respectively (Figure  3A). This produced a combined 
total of 1,250 lncRNAs across all four cell types, of which only a 
small proportion (3.5%) were shown to overlap with annotated 
lncRNAs in Gencode v23. Significantly, unlike the multi-exonic 
lncRNAs, only 24 of the 1,250 differentially expressed single 
exon lncRNAs were identified in two cell types and none were 
expressed in three or four cell types.
Using the percentage distribution across individual cell types, 
these were shown to be predominantly lincRNAs (78%), with 
9 http://bejerano.stanford.edu/great/public.
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FigUre 2 | Continued  
Characterization of differentially expressed long non-coding RNAs (lncRNAs) following activation of the human innate immune response. (a) Heatmap of the lncRNA 
expression levels in control and lipopolysaccharides (LPS) or interleukin-1β (IL1β) stimulated monocytes, macrophages, epithelium, and chondrocytes that have 
been subjected to unsupervised hierarchical based by experiment. (B) Venn diagram showing the overlap in the differentially expressed lncRNAs in LPS-stimulated 
monocytes and macrophages and IL1β-stimulated epithelial cells and chondrocytes at 4 h. (c) Pie charts showing the percentage distribution of repeat sequences 
in the various sub-populations of the differential expression lncRNAs across all four cell types with SINES = short interspersed nuclear elements, LINES = long 
interspersed nuclear elements, and LTR = long terminal repeat. (D) Pathways analysis of the messenger RNAs (mRNAs) located within 1 Mb of the differentially 
expressed lncRNA. (e) Pearson’s correlation between the differential expression of various lncRNA populations and that of the nearest mRNA.
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much smaller numbers of AS (3%), AS-downstream (7%), and 
AS-upstream (12%) (Figure  3B). As might be expected, these 
single exon lncRNAs were shorter in length than the multi-exonic 
lncRNAs at 0.6 kb (1.9 kb; p < 0.0001), 1.0 kb (1.5 kb; p = 0.0039), 
and 2.1 kb (2.4 kb; p < 0.0001) for AS-downstream, AS-upstream, 
and lincRNA, respectively (numbers in brackets show the length 
for multi-exonic lncRNAs; paired statistical testing using Mann 
Whitney). The exception was the AS at 3.6 kb, which were longer 
than the 2.9 kb seen in multi-exonic AS (p < 0.0001). Comparison 
of the absolute change in expression gave a value of 3.0 ±  0.3 
FPKM, a value not significantly different from 5.4 ± 3.1 FPKM 
seen with multi-exonic lncRNAs (Kruskal–Wallis test).
Once again, these single exon lncRNAs were also composed 
of large regions of repetitive sequences, which comprised 36, 31, 
26, and 29% of the AS, AS-downstream, AS-upstream, and lin-
cRNA sequences, respectively (Figure 3C). Assessment of their 
potential function identified 2,256 genes located within 1 Mb of 
these differentially expressed single exon lncRNAs and showed 
that these were also associated with immune activation and 
response (Figure 3D) and with the exception of AS-downstream 
that changes in expression correlated with those of the nearest 
mRNA (Figure 3E).
We were able to identify large numbers of differentially 
expressed single exon lncRNAs, whose expression was strongly 
cell type specific and correlated with that of adjacent immune-
related genes. However, we speculate that the vast majority 
represent artifacts related to the computational analysis and/or 
local non-specific transcriptional activity. Interestingly, although 
we showed significant increases in the expression of PACER 
(hXLOC_015084) in monocytes and chondrocytes (Table S6 in 
Supplementary Material), we were unable to detect the presence 
of THRIL (14). This is purported to be embedded (in the AS 
direction) within the 3′-untranslated region (UTR) of BRI3BP 
but detailed visual inspection in monocytes and macrophages (as 
well as the other two cell types) failed to identify the presence of 
this lncRNA (Data Sheet S3 in Supplementary Material).
lncrna expression in human Monocytes 
correlates with activating histone Marks
To validate our lncRNA catalog, we examined in control and 
LPS-stimulated monocytes the overlap between the lncRNAs 
and two active histone marks; H3K4me3, a marker of transcrip-
tional activity, and H3K27ac, a marker of active promoters and 
enhancers (40). Intersection of the peaks identified by MACS2 
and the mRNAs expressed in resting monocytes showed a partial 
overlap with H3K4me3 (25%) (Figure 4A) and H3K27ac (20%) 
(Figure 4B). In comparison, the overlap between the multi-exonic 
lncRNAs and H3K4me3 was reduced at 10%, while there was an 
increased intersection with the deposition of H3K27ac at 27%. By 
contrast, there was little overlap between the single exon lncRNAs 
and H3K4me3 (1%) or H3K27ac (4%).
To examine the differentially expressed lncRNAs, we sub-
sequently focused on the peaks identified following the same 
length of LPS stimulation in monocytes (4  h). As might be 
expected, the overlap between mRNAs and H3K4me3 (59%) 
(Figure  4C) and H3K27ac (62%) (Figure  4D) was greatly 
increased compared with resting cells and was comparable 
to the intersection seen with lncRNAs (H3K4me3 70% and 
H3K27ac 75%). In the case of differentially expressed single 
exons lncRNAs, the overlap was increased compared to controls 
(H3K4me3 24% and H3K27ac 44%) but did not reach the levels 
in mRNAs and lncRNAs. We further examined the profile of the 
two marks across the promoters (±3  kb) of the differentially 
expressed mRNAs and lncRNAs (Figures  4E,F). Although 
we were unable to detect a global increase in H3K4me3 and 
H3K27ac at the promoters of mRNAs (Figure 4E), the deposi-
tion of both H3K4me3 and H3K27ac was clearly increased for 
both the lncRNAs and single-exonic lncRNAs (Figure  4F). 
Overall, this ChIPseq analysis provides additional evidence 
to support our transcriptional analysis showing LPS-induced 
expression of multi-exonic lncRNAs and, to a lesser extent, 
single exon lncRNAs, in human monocytes. This also supports 
the existence of lncRNAs in resting monocytes, although the 
poor overlap with single exon lncRNAs indicates that many are 
indeed artifacts.
Widespread Differential expression  
of lncrnas following activation of the 
Mouse innate immune response
Further studies were undertaken to identify and characterize 
the differentially expressed lncRNAs following activation of 
the mouse innate immune response and to compare these with 
human lncRNAs. To this end, we undertook sequencing of LPS-
stimulated mouse RAW 264.7 macrophages and combined this 
with published sequencing data obtained from LPS-stimulated 
BMDMs (19), LPS-stimulated peritoneal macrophages (21), and 
LPS-stimulated splenic dendritic cells (21). Using the mouse 
Gencode database (m12), we showed differential expression 
(q < 0.05) of 1,293 mRNAs in BMDMs, 1,487 in RAW 264.7 mac-
rophages, 90 in peritoneal macrophages, and 24 in dendritic cells 
(Figure  5A; Table S7 in Supplementary Material). As with the 
human cells, KEGG pathway analysis (using DAVID bioinformat-
ics platform) (44) indicated activation of the immune response in 
all four cell types following exposure to LPS (Figure 5B).
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FigUre 3 | Continued  
Characterization of differentially expressed single exon long non-coding RNAs (lncRNAs) following activation of the human innate immune response. (a) Venn 
diagram showing the overlap in the single exon lncRNAs expression in resting monocytes, macrophages, epithelial cells, and chondrocytes. (B) Distribution of 
different lncRNA species in resting monocytes, macrophages, epithelial cells, and chondrocytes, and (c) Pie chart showing the percentage distribution of repeat 
sequences in the various sub-populations of lncRNAs across all four cell types with SINES = short interspersed nuclear elements, LINES = long interspersed 
nuclear elements, and LTR = long terminal repeat. (D) Pathways’ analysis of the messenger RNAs (mRNAs) located within 1 Mb of the differentially expressed 
lncRNA. (e) Pearson’s correlation between the differential expression of various lncRNA populations and that of the nearest mRNA.
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Following ab initio assembly, we identified 2,386 lncRNAs 
across the four mouse cell types that could be divided into 
869 lincRNAs (36%), 1,201 AS (50%), 170 AS-downstream 
(7%), and 146 AS-upstream (6%) (Table S8 in Supplementary 
Material). As a possible consequence of the poorer annotation 
of the mouse transcriptome, 1,592 (67%) of these were found 
to be novel lncRNAs. Following LPS stimulation, we showed 
differential expression of 210 lncRNAs (133 lincRNA, 34 AS, 
19 AS-downstream, and 24 AS-upstream; q  <  0.05) includ-
ing 69 in BMDMs, 158 in RAW macrophages, 7 in peritoneal 
macrophages, and 20 in dendritic cells (Figure 5C; Table S8 in 
Supplementary Material). As with human cells, examination of 
the overlap between cell types showed that the vast majority (171 
or 81%) were expressed in a cell-specific manner. Of the remain-
der, 36 were found in two cell types and 4 were found in three cell 
types (Figure 5C). Interestingly, our ab initio assembly identified 
three lncRNAs that have previously been shown to regulate the 
innate immune response: lincRNA-COX2 (mXLOC_001674) (17, 
18), lincRNA-EPS (mXLOC_029096) (19), and lincRNA-Tnfaip3 
(mXLOC_003831) (20). Differential expression in response to LPS 
was seen with lincRNA-COX2 (BMDMs, RAW macrophages, and 
peritoneal macrophages) and lincRNA-EPS (RAW macrophages) 
but not lincRNA-Tnfaip3 (Table S9 in Supplementary Material).
Characterization of these differentially expressed lncRNAs 
showed that these were broadly similar to that observed in 
humans. Thus, these were found to be composed of ~30% repeat 
elements (Figure 5D). Functional analysis identified 540 genes 
located within 1 Mb of the differentially expressed lncRNAs and 
showed that these were associated with immune activation and 
response (Figure 5E), while the fold change in expression of the 
nearest mRNA was showed to correlate with the changes in AS 
(r = 0.7952, p < 0.0001) and lincRNAs (r = 0.4209, p < 0.0001) 
(Figure 5F).
Our analysis of sequencing data from multiple mouse cell 
types identified 210 lncRNAs that were differentially expressed 
following induction of the innate immune response. These 
demonstrated comparable characteristics to those observed in 
humans including cell-specific expression, large regions of repeat 
sequences, and correlation between their expression and that of 
local inflammatory genes.
identification of Microdomains  
in Differentially expressed human  
and Mouse lncrnas
It has been speculated that the action of lncRNAs is mediated 
through microdomains that interact with proteins or undergo 
base pairing with RNA and/or DNA. To identify potential 
microdomains, we searched for conserved sequences within our 
catalogs of differentially expressed lncRNA genes. As previously 
reported (46), our initial analysis of the evolutionary conserva-
tion of lncRNAs showed that these were poorly conserved 
(Figure  6A). Thus, using PhastCons (seven-way vertebrate), 
which determines conservation on a 0–1 scale (1 being the most 
conserved), we obtained values of 0.162, 0.165, 0.151, and 0.161 
with the human AS, AS-downstream, AS-upstream, and lincR-
NAs, respectively. This value was significantly greater than the 
0.099 ±  0.002 for the intronic regions of protein-coding genes 
(p < 0.0001—Mann–Whitney U-test) but considerably less than 
the value for exonic, 5′- and 3′-UTRs of protein-coding genes 
at 0.842 ± 0.001, 0.376 ± 0.011, and 0.373 ± 0.001, respectively 
(Figure 6A). Similarly, PhastCons analysis of the mouse catalog 
(vertebrate 60-way) produced values of 0.246 for AS and 0.182 
for lincRNAs, which were significantly greater than those seen 
for intronic regions (p <  0.0001—Mann–Whitney U-test) but 
less than the value for exonic, 5′- and 3′-UTRs of protein-coding 
genes (Figure 6A).
Despite this poor overall evolutionary conservation, we 
proceeded to look for the presence of microdomains through 
comparison of the lncRNAs. This was performed following 
the removal of the repeat sequences using Repeatmasker (see 
text footnote 5). These lncRNAs gave a mean length of 4.7  kb 
(human) and 4.0 kb (mouse) and were shown to be rich in AT 
residues (58% for human and 54% for mouse). Analysis using 
MEME-ChIP (37) identified three conserved microdomains in 
the human lncRNA catalog but found nothing within the mouse 
lncRNA catalog (Figure 6B). In subsequent studies, we employed 
BLASTn (38) to identify shared regions within the human and 
mouse lncRNA catalogs. The output was compared with a com-
parable number of randomly generated control sequences and 
protein-coding genes, of similar lengths and AT composition. 
This analysis showed <1% overall conservation but identified 
5,130 and 4,199 significant hits of lengths 12–50 nt in the human 
and mouse lncRNA catalogs, respectively (Figure 6C). This was 
significantly higher [p <  0.0001: one-way analysis of variance 
(ANOVA)] than the 1,511 and 1,264 regions identified in the 
human and mouse control sequences. Protein-coding genes 
showed comparable number of hits to lncRNAs around the peak 
of 20 nt, but overall number of hits was elevated throughout the 
12–50 nt range (Figure 6C). Submission of the BLASTn hits from 
the human and mouse lncRNA catalogs into MEME-ChIP identi-
fied 4 and 10 microdomains, respectively. No microdomains were 
detected in the controls. When we compared these motifs with 
the ATtRACT database of RNA-biding proteins and associated 
motifs (47), we found that a four of them (three in human and 
one in mouse) had positive hits with known RNA-binding pro-
teins (Figures 6D,E). In general, these proteins were found to be 
involved in mRNA splicing, stability, and transport. Thus, despite 
FigUre 4 | Analysis of the overlap between mRNAs/lncRNAs and histone marks in human monocytes ChIPSeq data from resting (a,B) and lipopolysaccharides 
(LPS)-stimulated (c,D) is expressed as the percentage of long non-coding RNA (lncRNA) and messenger RNA (mRNA) genes that overlap with peaks identified by 
MACS2 (% genomic overlap) for H3K4me3 (a marker of transcriptional activity) (a,c) and H3K27ac (a marker of active enhancers/promoters) (B,D). Heatmaps were 
generated (lower panel) displaying the deposition of H3K4me3 and H3K27ac across the promoters (TSS ± 3 kb) of differentially expressed mRNAs (e) and lncRNAs 
(F). The upper panel displays the mean deposition of reads across all of the regions in the heatmap.
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FigUre 5 | Continued  
Characterization of differentially expressed long non-coding RNAs (lncRNAs) following activation of the mouse innate immune response. (a) Venn diagram showing the 
overlap in the differentially expressed messenger RNAs (mRNAs) in lipopolysaccharides (LPS)-stimulated bone marrow macrophages, RAW 264.7 macrophages, 
peritoneal macrophages, and splenic dendritic cells. (B) Pathway analysis of the differentially expressed mRNA across all cell types. (c) Venn diagram showing the 
overlap in the differentially expressed lncRNAs in LPS-stimulated bone marrow macrophages, RAW 264.7 macrophages, peritoneal macrophages, and splenic dendritic 
cells. (D) Pie charts showing the percentage distribution of repeat sequences in the differentially expressed lncRNAs across all four cell types with SINES = short 
interspersed nuclear elements, LINES = long interspersed nuclear elements, and LTR = long terminal repeat. (e) Pathways analysis of the mRNAs located within 1 Mb 
of the differentially expressed lncRNAs. (F) Pearson’s correlation between the differential expression of various lncRNA populations and that of the nearest mRNA.
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the poor evolutionary conservation, this analysis indicated that 
the differentially lncRNA contains short conserved regions or 
microdomains that might be important in mediating their func-
tions and mechanism of action.
identification of syntenic lncrnas  
in the human and Mouse innate  
immune responses
No homology was observed between the differentially expressed 
human and mouse lncRNA catalogs. Since it has been suggested 
that genomic position might be important to their biological 
action, we compared the human and mouse catalogs to identify 
those demonstrating synteny. Our analysis showed that 21 (10%) 
of the differentially expressed human lncRNAs had syntenic ver-
sions in mice and included the two human lncRNAs that were 
differentially expressed in all human cell types, hXLOC_405581 
(which mapped to mouse mXLOC_025443) and hXLOC_367599 
(which mapped to mXLOC_003168) (Table S10 in Supplementary 
Material). However, only five of these syntenic mouse lncRNAs were 
also significantly differentially expressed (p < 0.05) in a least one 
mouse cell type and included mXLOC_014053 (hXLOC_246791), 
mXLOC_039871 (hXLOC_039871), ENSMUSG00000097180 
(hXLOC_376116), mXLOC_025443 (hXLOC_405581), and 
mXLOC_044198 (hXLOC_455493). With a mean of 9%, BLASTn 
analysis showed increased conservation across these syntenic 
genes, compared to all differentially expressed lncRNAs (<1%), 
although there was a wide variation (0–53%) (Table S10 in 
Supplementary Material).
il7-as regulates the inflammatory 
response in human and Mice
In order to validate the sequencing data, we employed qRT-PCR 
to measure the levels of five lncRNAs across three human cell 
types (monocytes, macrophages, and epithelial A549 cells) and 
showed a significant correlation between the fold changes follow-
ing differential expression (Figure 7A). To assess the biological 
relevance of these lncRNA catalogs, we examined the function 
of the syntenic lncRNAs, hXLOC_405581 and mXLOC_025443, 
that is differentially expressed in multiple human and mouse cell 
types. These were renamed hIL7-AS and mIL7-AS as a result of 
their AS overlap with the promoter region of IL7, a cytokine that 
has been implicated in T- and B-cell development (48). Analysis 
of the structure of human and mouse IL7-AS showed that these 
were complex genes that could be assembled potentially into 
multiple transcripts. In the case of the human hIL7-AS, sequenc-
ing data indicated the existence of up to nine exons (however, for 
simplicity, we have only shown the four most represented exons, 
Figure 7B), which could be assembled into potentially four tran-
scripts of a gene of up to 10,280 nt in length (including 34% repeat 
sequences). In contrast, the mouse mIL7-AS was somewhat less 
complex containing up to five exons that could be assembled into 
four potential transcripts giving a gene of an approximate length 
of 5,043 nt (including 63% repeat sequences, Figure 7C).
To facilitate the functional analysis of IL7-AS, experiments 
were performed using IL1β-stimulated human A549 lung 
epithelial cells, LPS-stimulated human monocytic THP-1 cells, 
and LPS-stimulated mouse RAW 264.7 macrophages, which are 
amenable to transfection. In all cell types, measurement of time 
courses shows a similar rapid increase in hIL7-AS and mIL7-AS 
expressions, peaking between 4 and 6 h and remaining elevated 
at 24  h (Figure  7D). Examination of IL7 expression showed a 
parallel production of IL7 mRNA, albeit a smaller fold increase, 
in activated human A549 epithelium and THP-1 monocyte cells, 
but not mouse RAW 264.7 cells, where IL7 expression does not 
seem to be affected by LPS stimulation (Figure 7D). Although 
IL7 expression seems to correlate with the expression of hIL7-AS 
in A549 and THP-1 cells, it is interesting to note that the absolute 
expression of IL7, according to our sequencing data, is at least 
10 times lower than the expression of hIL7-AS (IL7 = 0.6 FPKM 
vs hIL7-AS = 7.0 FPKM in A549 and IL7 = 5.5 FPKM vs hIL7-
AS = 182.2 FPKM in monocyte).
Most lncRNAs present a bias toward nuclear localization, 
where previous studies of functional lncRNAs have been shown 
to regulate the transcription of protein-coding genes (7, 49, 50). 
We therefore investigated the subcellular localization of IL7-AS 
in human cell lines (Figure 7E). Indeed, the expression of hIL7-
AS was enriched in the nuclear fraction, compared to the whole 
lysate. We also looked at the expression of NEAT-1, a lncRNA 
known to be mainly located in the nucleus (51) and the mito-
chondrially encoded cytochrome B (MT-CYB) gene, produced 
from mitochondrial DNA in the cytoplasm (52). As expected, 
both NEAT-1 and MT-CYB were shown to be enriched, respec-
tively, in the nucleus and in the cytoplasm fraction (Figure 7E), 
confirming that the separation procedure was successful.
To examine whether IL7-AS has a role in the innate immune 
response, we used AS locked nucleic acid (LNA) to knockdown the 
expression of IL7-AS RNA in both human and mouse. In human, 
we selected two AS LNAs targeting exon 1 (LNA 1) and exon 4 
(LNA 2) that attenuated both IL1β- and LPS-induced hIL7-AS 
production by 50–85% at 24 h (Figure 7F) of A549 and THP-1 
cells, respectively. Likewise, in mouse, selected AS LNAs, targeting 
exon 1 (LNA 1) and exon 3 (LNA 2), showed similar knockdown 
of mIL7-AS than in human cell lines (Figure 7F). Knockdown did 
not significantly impact upon IL7 mRNA production indicating 
FigUre 6 | Identification of conserved microdomains in the differentially expressed human and mouse long non-coding RNAs (lncRNAs). (a) PhastCons analysis 
of the conservation of the differentially expressed lncRNA species in human and mouse cells compared with the exon, intronic, and untranslated regions (UTRs) of 
protein-coding genes. (B) Identification of conserved microdomains within human lncRNA sequences using the MEME-suite (following removal of repeat 
sequences). (c) Distribution of hits obtained from the BLASTn analysis of lncRNAs, matched random controls, and matched protein-coding genes in human and 
mouse. (D,e) Identification of conserved microdomains within human (D) and mouse (e) BLASTn data.
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FigUre 7 | Continued
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FigUre 7 | Continued  
IL7-AS regulates the expression and release of IL6 from interleukin-1β (IL1β)- and lipopolysaccharides (LPS)-stimulated human and mouse cells. (a) Comparison of 
fold change in expression of differentially expressed lncRNAs using RNA sequencing and qRT-PCR. Structure and profile of IL7-AS expression in (B) human and (c) 
mouse cells visualized using the Integrated Genomics Viewer (IGV). (D) Time course of IL7-AS and IL7 mRNA production in IL1β-stimulated human alveolar A549 
epithelium and LPS-stimulated human THP1 monocytes and mouse RAW 264.7 macrophages (n = 3 independent experiments). (e) Subcellular distribution of 
IL7-AS in IL1β-stimulated A549 epithelium and LPS-stimulated THP1 monocytes in which NEAT-1 and mitochondrial-cytochrome b (MT-CYB) are employed as 
markers of nuclear and cytoplasmic fractions, respectively (n = 4 independent experiments). (F) Effect of transfection with a negative control LNA (scramble) or two 
antisense LNA (LNA 1 or 2) targeting, respectively, exons 1 and 4 (human cells) or exons 1 and 3 (mouse cells) of IL7-AS at a final concentration of 30 nM. Cells 
were then treated with either IL1β (30 ng/ml) or LPS (1 µg/ml), or left untreated for 24 h, prior to measurement of levels of the stated gene (by q-PCR) or proteins (by 
ELISA) (n = 7–8 independent experiments). Statistical significance was performed using either two-way analysis of variance (ANOVA) for time courses or repeated 
measure one-way ANOVA with both a Dunnett’s post-test correction, where *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 versus control.
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that although IL7-AS and IL7 overlap at their promoter region, 
the action of IL7-AS is not mediated through IL7 regulation in 
cis (Figure 7F). Instead, these results suggest that any potential 
biological actions of IL7-AS might be mediated in trans. Indeed, 
IL7-AS knockdown showed significant modulation of the IL1β- 
and LPS-induced expressions of the pro-inflammatory mediator 
IL6 on both mRNA production and release of the cytokine in 
human and in mouse (Figure  7F). Interestingly, IL1β-induced 
IL6 production was significantly down-regulated in A549 cells 
upon IL7-AS knockdown, while in THP-1 and RAW 264.7 cells, 
knockdown showed an upregulation of LPS-induced IL6 produc-
tion (Figure 7F). These results suggest that IL7-AS function on 
IL6 production is cell and/or stimuli specific.
Overall, these studies provide evidence of the utility of using 
differential expression as the basis for identifying functional 
lncRNA in the innate immune response and have for the first time 
identified a lncRNA (i.e., IL7-AS) that regulates the inflammatory 
response in both human and mouse models.
DiscUssiOn
Using next-generation sequencing data from four human and 
four mouse cell types, we have undertaken the first comprehen-
sive analysis of the changes in lncRNA expression associated 
with the activation of the innate immune response. This is 
important since differential expression has commonly provided 
the initial step in the search for functional lncRNAs and has 
led to the identification a number that regulate the associated 
inflammatory response including PACER (13), THRIL (14), lnc-
IL7R (15), and IL1β-RBT46 (16) in humans and lincRNA-COX2 
(17, 18), lincRNA-EPS (19), and lincRNA-Tnfaip3 (20) in mice. 
Differential expression has also been employed to compare T- and 
B-cell populations and identified lncRNAs that regulate multiple 
aspects of the adaptive immune response including activation, 
proliferation, and differentiation (53–55). Using this approach, 
we have demonstrated differential expression of 204 human and 
210 mouse lncRNAs, which included PACER (13), IL1β-RBT46 
(16), lincRNA-COX2 (17, 18), and lincRNA-EPS (19). Intriguingly, 
we were unable to detect the expression of THRIL (14), lnc-IL7R 
(15), or lincRNA-Tnfaip3 (20), which were all located within 
the 3′ UTRs of known protein-coding genes and were initially 
detected using microarrays. In future, we therefore believe that 
visual annotation of sequencing data should be the method of 
choice when identifying novel lncRNAs. In order to produce 
as comprehensive a lncRNA catalog as possible, sequencing 
of two of the eight cell types (human epithelial A549 cells and 
the mouse macrophage RAW264.7 cells) was undertaken after 
polyA+ selection (rather than ribozero selection). This is likely 
to influence the comparison between cell types and, specifically, 
might reduce the number of lncRNAs detected, since we would 
be unable to identify those lacking polyA+ tails. Although it is 
difficult to assess the potential impact of polyA+ versus ribozero 
isolation, the similarity in the numbers of differentially expressed 
lncRNAs in epithelial A549 cells (39 lncRNAs), compared with 
monocytes (105 lncRNAs), macrophages (50 lncRNAs), and 
chondrocytes (65 lncRNAs), indicates that we may be omitting 
only a small number.
As a part of our analysis, we also investigated the changes in 
single exon transcripts, which are traditionally excluded from 
the lncRNA classification (which requires two or more exons). 
This work suggests that, although a number of these are likely 
to regulate the innate immune response (i.e., PACER) (13), the 
large numbers and the wide variation between cell types indicate 
that the majority represent transcriptional noise and/or are an 
artifact of the analysis pathway. This conclusion is supported by 
the ChIPseq analysis in human monocytes that showed a poor 
overlap between markers of active transcription and enhancers/
promoters.
Analysis of the full-length genes demonstrated weak con-
servation through evolution, as well as between the lncRNAs 
(<1%) and showed no homology between the human and mouse 
catalogs. However, a combination of BLASTn and MEME-ChIP 
allowed the identification of multiple conserved microdomains 
of lengths 5–30 nt. We speculate that these microdomains might 
mediate the actions of lncRNAs, either through protein bind-
ing and/or base pairing to RNA/DNA. Previous reports have 
uncovered only lncRNA–protein interactions, including an 
action of lincRNA-COX2 (17, 18), THRIL (14), and lincRNA-
EPS (19) through heterogeneous ribonucleoproteins and 
PACER via the p50 component of NF-κB (13). Of relevance, 
the identification of microdomains was performed following 
the removal of the repeats that comprised ~30% of lncRNA 
sequences. However, it is possible that repeats are important in 
mediating the action of lncRNA, with previous studies show-
ing that Alu repeats can activate the inflammasome (51) and 
contain binding sites for transcription factors involved in regu-
lating the macrophage response to Mycobacterium tuberculosis  
infection (56).
It has also been suggested that the maintenance of genomic 
position relative to protein-coding genes (synteny) might be 
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important in determining the lncRNA function. Comparison 
across humans and mouse identified 22 syntenic lncRNAs, of 
which five were differentially expressed in both species. This 
included IL7-AS (located AS to IL7), which was induced across 
multiple human and mouse cell types and demonstrated the larg-
est changes in absolute expression among the syntenic lncRNAs. 
Measurement of IL6 transcription and secretion showed that 
IL7-AS was a positive regulator of IL1β-induced inflammatory 
response in human A549 epithelial cell but a negative regulator in 
LPS-stimulated human THP-1 monocytes and mouse RAW 264.7 
macrophages. Given our previous report showing that IL7-AS (or 
CILinc02) was a negative regulator of IL1β-stimulated IL6 release 
from human chondrocytes (57), this indicates that its actions are 
cell-type specific rather than stimulus specific. Future studies will 
need to ascertain whether this is related to alternative splicing 
and/or cell-specific differences in lncRNA mechanisms. In addi-
tion, since IL7-AS is the first lncRNA to demonstrate function 
in the innate immune response in both human and mouse cell 
models, this provide an opportunity to compare the physiological 
role of lncRNAs across these two species.
In summary, we have for the first time cataloged and charac-
terized those lncRNAs that are differentially expressed in multiple 
human and mouse cell types following activation of the innate 
immune response. However, further studies will be necessary to 
determine which other lncRNAs are functional from those two 
catalogs. Indeed, a refined list of functional lncRNAs could give 
us fewer and/or more defined microdomains. It is envisaged that 
this will provide an important resource for the discovery of func-
tional lncRNAs and elucidation of their mechanism of action.
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